Xiangmin Cui

Xiangmin Cui has an estimated net worth of $81.1 Million. This is based on reported shares across multiple companies, which include CG Oncology, Inc., China Biologic Products, Inc., ALPINE IMMUNE SCIENCES, INC., Cue Health Inc., ARMO BioSciences, Inc., Equillium, Inc., Nuvation Bio Inc., Aardvark Therapeutics, Inc., and BeyondSpring Inc..

2024 was Xiangmin Cui's most active year for acquiring shares with 21 total transactions. Xiangmin Cui's most active month to acquire stocks was the month of December. 2025 was Xiangmin Cui's most active year for disposing of shares, totalling 65 transactions. Xiangmin Cui's most active month to dispose stocks was the month of August. 2019 saw Xiangmin Cui paying a total of $23,629,992.27 for 4,408,021 shares, this is the most they've acquired in one year. In 2018 Xiangmin Cui cashed out on 2,447,400 shares for a total of $60,915,540.00, their largest year based on trade value.